Screener
LeMaitre Vascular LMAT Treasury Stock
Treasury Stock at other companies
Other financials
Where this comes from
Reported directly by LeMaitre Vascular in its filing.
Tagged under the XBRL concept us-gaap:TreasuryStockCommonValue.
The source filing: LeMaitre Vascular’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 6:30 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333762
| Line item | (unaudited) / June 30, 2026 | December 31, 2025 |
|---|---|---|
| Preferred stock, $0.01 par value; 3,000,000 shares authorized; none issued and outstanding | — | — |
| Common stock, $0.01 par value; 37,000,000 shares authorized, 24,494,202 and 24,396,904 shares issued, 22,864,935 and 22,772,607 shares outstanding, respectively | 245 | 244 |
| Additional paid-in capital | 236,161 | 228,407 |
| Retained earnings | 206,017 | 184,715 |
| Accumulated other comprehensive loss | (4,165) | (2,411) |
| Treasury stock, at cost; 1,629,267 and 1,624,297 shares, respectively | (17,916) | (17,439) |
| Total stockholders’ equity | 420,342 | 393,516 |
| Total liabilities and stockholders’ equity | $640,549 | $615,690 |
Item 1. Financial Statements
FAQ
- What is LeMaitre Vascular's treasury stock?
- LeMaitre Vascular (LMAT) reported treasury stock of $17.92M in Q2 2026.
- How has LeMaitre Vascular's treasury stock changed year-over-year?
- LeMaitre Vascular's treasury stock increased by 10.4% year-over-year, from $16.22M to $17.92M.
- What is the long-term trend for LeMaitre Vascular's treasury stock?
- Over 5 years (2020 to 2025), LeMaitre Vascular's treasury stock has grown at a 8.5% compound annual growth rate (CAGR), from $11.6M to $17.44M.
- What does treasury stock mean?
- Shares repurchased by the company and held in treasury, reducing equity. Recorded at cost and presented as a negative equity component.
Ask your AI about LeMaitre Vascular's treasury stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude